Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast
LEXINGTON, Mass., Nov. 05, 2024 ( GLOBE NEWSWIRE ) -- Voyager Therapeutics, Inc. ( Nasdaq: VYGR ) , a biotechnology company dedicated to advancing neurogenetic medicines, today announced it will report third quarter 2024 financial and operating results after market close on Tuesday, November 12, ...
| Ticker |
Sentiment |
Impact |
|
SGMO
|
Neutral
|
16 %
|
|
AZN
|
Neutral
|
16 %
|
|
VYGR
|
Somewhat Bullish
|
68 %
|
|
NBIX
|
Neutral
|
16 %
|
